Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cross Infection | 6 | 2014 | 149 | 0.860 |
Why?
|
| Disease Outbreaks | 7 | 2017 | 147 | 0.710 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2011 | 112 | 0.480 |
Why?
|
| Adenovirus Infections, Human | 2 | 2007 | 3 | 0.430 |
Why?
|
| Influenza, Human | 3 | 2011 | 347 | 0.410 |
Why?
|
| Population Surveillance | 2 | 2011 | 212 | 0.390 |
Why?
|
| Diarrhea | 2 | 2011 | 176 | 0.390 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 3 | 2016 | 12 | 0.340 |
Why?
|
| Infection Control | 2 | 2015 | 130 | 0.310 |
Why?
|
| Clostridium Infections | 1 | 2011 | 126 | 0.300 |
Why?
|
| Foodborne Diseases | 1 | 2008 | 9 | 0.280 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 31 | 0.230 |
Why?
|
| Adenoviruses, Human | 2 | 2007 | 41 | 0.230 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2006 | 70 | 0.220 |
Why?
|
| Child, Preschool | 7 | 2017 | 3781 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 557 | 0.200 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 284 | 0.190 |
Why?
|
| Infant | 5 | 2017 | 3156 | 0.180 |
Why?
|
| Hospitals, Chronic Disease | 1 | 2001 | 2 | 0.170 |
Why?
|
| Child | 6 | 2017 | 7273 | 0.150 |
Why?
|
| Adolescent | 7 | 2017 | 9550 | 0.150 |
Why?
|
| Coronavirus Infections | 2 | 2015 | 333 | 0.150 |
Why?
|
| Herpesvirus 1, Human | 3 | 1996 | 210 | 0.150 |
Why?
|
| Herpesvirus 2, Human | 2 | 1996 | 20 | 0.150 |
Why?
|
| Kaposi Varicelliform Eruption | 2 | 2008 | 5 | 0.140 |
Why?
|
| Smallpox Vaccine | 2 | 2008 | 11 | 0.140 |
Why?
|
| Feces | 2 | 2011 | 360 | 0.130 |
Why?
|
| Illinois | 2 | 2011 | 515 | 0.130 |
Why?
|
| Tularemia | 1 | 1997 | 8 | 0.130 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1997 | 8 | 0.130 |
Why?
|
| Enterovirus D, Human | 1 | 2017 | 4 | 0.130 |
Why?
|
| Pneumonia, Bacterial | 1 | 1997 | 30 | 0.130 |
Why?
|
| Enterovirus Infections | 1 | 2017 | 25 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 109 | 0.120 |
Why?
|
| Chicago | 3 | 2011 | 1452 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2008 | 278 | 0.120 |
Why?
|
| Travel | 2 | 2015 | 73 | 0.120 |
Why?
|
| Viral Envelope Proteins | 1 | 1995 | 79 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2016 | 95 | 0.110 |
Why?
|
| Pandemics | 2 | 2011 | 873 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 296 | 0.110 |
Why?
|
| Hospitals | 2 | 2011 | 329 | 0.110 |
Why?
|
| Long-Term Care | 2 | 2007 | 63 | 0.100 |
Why?
|
| Adult | 9 | 2016 | 27849 | 0.100 |
Why?
|
| Family Health | 2 | 2011 | 154 | 0.100 |
Why?
|
| Young Adult | 4 | 2011 | 6922 | 0.090 |
Why?
|
| Humans | 18 | 2017 | 93130 | 0.090 |
Why?
|
| Age Distribution | 1 | 2011 | 206 | 0.080 |
Why?
|
| Patient Transfer | 1 | 2011 | 107 | 0.080 |
Why?
|
| Schools | 1 | 2011 | 84 | 0.080 |
Why?
|
| Disease Transmission, Infectious | 1 | 2011 | 56 | 0.080 |
Why?
|
| Nursing Homes | 1 | 2011 | 108 | 0.080 |
Why?
|
| Male | 10 | 2017 | 44353 | 0.080 |
Why?
|
| Female | 10 | 2017 | 48540 | 0.070 |
Why?
|
| Fomites | 1 | 2008 | 2 | 0.070 |
Why?
|
| Vaccinia virus | 1 | 2008 | 20 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 396 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2011 | 364 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2011 | 2427 | 0.070 |
Why?
|
| Escherichia coli O157 | 1 | 2008 | 2 | 0.070 |
Why?
|
| Salmonella | 1 | 2008 | 14 | 0.070 |
Why?
|
| Logistic Models | 1 | 2011 | 1240 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2011 | 373 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2017 | 4546 | 0.060 |
Why?
|
| Health Facilities | 1 | 2007 | 39 | 0.060 |
Why?
|
| Incidence | 1 | 2011 | 1697 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 576 | 0.060 |
Why?
|
| Middle Aged | 5 | 2014 | 27535 | 0.060 |
Why?
|
| Health Personnel | 2 | 2014 | 234 | 0.060 |
Why?
|
| Aged | 3 | 2011 | 20395 | 0.060 |
Why?
|
| Heparin | 2 | 1996 | 177 | 0.050 |
Why?
|
| Antibodies, Viral | 3 | 2014 | 320 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 7039 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 284 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 618 | 0.050 |
Why?
|
| Angiostrongylus cantonensis | 1 | 2002 | 1 | 0.050 |
Why?
|
| Strongylida Infections | 1 | 2002 | 7 | 0.050 |
Why?
|
| Meningitis, Aseptic | 1 | 2002 | 6 | 0.050 |
Why?
|
| Vero Cells | 3 | 1996 | 98 | 0.040 |
Why?
|
| Serotyping | 2 | 1996 | 28 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2011 | 10128 | 0.040 |
Why?
|
| Francisella tularensis | 1 | 1997 | 9 | 0.030 |
Why?
|
| Ohio | 1 | 2017 | 42 | 0.030 |
Why?
|
| DNA, Viral | 2 | 2008 | 234 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 1997 | 85 | 0.030 |
Why?
|
| Pharynx | 1 | 2017 | 44 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 1997 | 85 | 0.030 |
Why?
|
| Nose | 1 | 2017 | 95 | 0.030 |
Why?
|
| Medical Records | 1 | 2017 | 121 | 0.030 |
Why?
|
| United States | 4 | 2015 | 7581 | 0.030 |
Why?
|
| Saudi Arabia | 1 | 2016 | 17 | 0.030 |
Why?
|
| Pediatrics | 1 | 2001 | 378 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 118 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 1997 | 258 | 0.030 |
Why?
|
| Heparitin Sulfate | 1 | 1995 | 25 | 0.030 |
Why?
|
| Seasons | 1 | 2017 | 239 | 0.030 |
Why?
|
| Neutrophils | 1 | 1997 | 324 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 1995 | 72 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 1995 | 73 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 1995 | 86 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 753 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1995 | 192 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 838 | 0.030 |
Why?
|
| Africa, Western | 1 | 2015 | 12 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 528 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 2889 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 267 | 0.030 |
Why?
|
| Jordan | 1 | 2014 | 10 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2014 | 56 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 1022 | 0.030 |
Why?
|
| Species Specificity | 1 | 1995 | 683 | 0.030 |
Why?
|
| Base Sequence | 1 | 1995 | 2207 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 1997 | 833 | 0.020 |
Why?
|
| Hospitalization | 1 | 2017 | 924 | 0.020 |
Why?
|
| Respiratory Protective Devices | 1 | 2011 | 3 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2011 | 51 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2011 | 65 | 0.020 |
Why?
|
| Asthma | 1 | 2017 | 1039 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 3128 | 0.020 |
Why?
|
| Isoindoles | 1 | 2008 | 13 | 0.020 |
Why?
|
| Plasma | 1 | 2008 | 48 | 0.020 |
Why?
|
| Organophosphonates | 1 | 2008 | 46 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 152 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2008 | 67 | 0.020 |
Why?
|
| Cytosine | 1 | 2008 | 121 | 0.020 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 65 | 0.020 |
Why?
|
| Benzamides | 1 | 2008 | 246 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2008 | 191 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1318 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 888 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 465 | 0.010 |
Why?
|
| Animals | 4 | 2002 | 27968 | 0.010 |
Why?
|
| Structure-Activity Relationship | 2 | 1996 | 422 | 0.010 |
Why?
|
| Jamaica | 1 | 2002 | 5 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 2002 | 10 | 0.010 |
Why?
|
| Headache | 1 | 2002 | 75 | 0.010 |
Why?
|
| Eosinophilia | 1 | 2002 | 87 | 0.010 |
Why?
|
| Intracranial Hypertension | 1 | 2002 | 55 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2002 | 289 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 1995 | 17 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1995 | 18 | 0.010 |
Why?
|
| Carbohydrate Conformation | 1 | 1995 | 18 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 3044 | 0.010 |
Why?
|
| Virion | 1 | 1995 | 61 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 421 | 0.010 |
Why?
|
| Kinetics | 1 | 1995 | 1463 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1995 | 661 | 0.010 |
Why?
|
| Risk Factors | 1 | 2002 | 5900 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1908 | 0.010 |
Why?
|
| Cell Line | 1 | 1995 | 2458 | 0.010 |
Why?
|